@article{townsley_koutouan_mayorga_mills_davis_hasmiller lich_2022, title={When History and Heterogeneity Matter: A Tutorial on the Impact of Markov Model Specifications in the Context of Colorectal Cancer Screening}, volume={5}, ISSN={["1552-681X"]}, DOI={10.1177/0272989X221097386}, abstractNote={Background Markov models are used in health research to simulate health care utilization and disease states over time. Health phenomena, however, are complex, and the memoryless assumption of Markov models may not appropriately represent reality. This tutorial provides guidance on the use of Markov models of different orders and stratification levels in health decision-analytic modeling. Colorectal cancer (CRC) screening is used as a case example to examine the impact of using different Markov modeling approaches on CRC outcomes. }, journal={MEDICAL DECISION MAKING}, author={Townsley, Rachel M. and Koutouan, Priscille R. and Mayorga, Maria E. and Mills, Sarah D. and Davis, Melinda M. and Hasmiller Lich, Kristen}, year={2022}, month={May} }
 @article{powell_frerichs_townsley_mayorga_richmond_corbie-smith_wheeler_lich_2020, title={The potential impact of the Affordable Care Act and Medicaid expansion on reducing colorectal cancer screening disparities in African American males}, volume={15}, ISSN={["1932-6203"]}, DOI={10.1371/journal.pone.0226942}, abstractNote={Few investigations have explored the potential impact of the Affordable Care Act on health disparity outcomes in states that chose to forgo Medicaid expansion. Filling this evidence gap is pressing as Congress grapples with controversial healthcare legislation that could phase out Medicaid expansion. Colorectal cancer (CRC) is a commonly diagnosed, preventable cancer in the US that disproportionately burdens African American men and has substantial potential to be impacted by improved healthcare insurance coverage. Our objective was to estimate the impact of the Affordable Care Act (increasing insurance through health exchanges alone or with Medicaid expansion) on colorectal cancer outcomes and economic costs among African American and White males in North Carolina (NC), a state that did not expand Medicaid. We used an individual-based simulation model to estimate the impact of ACA (increasing insurance through health exchanges alone or with Medicaid expansion) on three CRC outcomes (screening, stage-specific incidence, and deaths) and economic costs among African American and White males in NC who were age-eligible for screening (between ages 50 and 75) during the study period, years of 2013–2023. Health exchanges and Medicaid expansion improved simulated CRC outcomes overall, though the impact was more substantial among AAs. Relative to health exchanges alone, Medicaid expansion would prevent between 7.1 to 25.5 CRC cases and 4.1 to 16.4 per 100,000 CRC cases among AA and White males, respectively. Our findings suggest policies that expanding affordable, quality healthcare coverage could have a demonstrable, cost-saving impact while reducing cancer disparities.}, number={1}, journal={PLOS ONE}, author={Powell, Wizdom and Frerichs, Leah and Townsley, Rachel and Mayorga, Maria and Richmond, Jennifer and Corbie-Smith, Giselle and Wheeler, Stephanie and Lich, Kristen Hassmiller}, year={2020}, month={Jan} }
 @article{lich_meghan c. o'leary_nambiar_townsley_mayorga_hicklin_frerichs_shafer_davis_wheeler_2019, title={Estimating the impact of insurance expansion on colorectal cancer and related costs in North Carolina: A population-level simulation analysis}, volume={129}, ISSN={["1096-0260"]}, url={http://dx.doi.org/10.1016/j.ypmed.2019.105847}, DOI={10.1016/j.ypmed.2019.105847}, abstractNote={Although screening is effective in reducing incidence, mortality, and costs of treating colorectal cancer (CRC), it remains underutilized, in part due to limited insurance access. We used microsimulation to estimate the health and financial effects of insurance expansion and reduction scenarios in North Carolina (NC). We simulated the full lifetime of a simulated population of 3,298,265 residents age-eligible for CRC screening (ages 50-75) during a 5-year period starting January 1, 2018, including polyp incidence and progression and CRC screening, diagnosis, treatment, and mortality. Insurance scenarios included: status quo, which in NC includes access to the Health Insurance Exchange (HIE) under the Affordable Care Act (ACA); no ACA; NC Medicaid expansion, and Medicare-for-all. The insurance expansion scenarios would increase percent up-to-date with screening by 0.3 and 7.1 percentage points for Medicaid expansion and Medicare-for-all, respectively, while insurance reduction would reduce percent up-to-date by 1.1 percentage points, compared to the status quo (51.7% up-to-date), at the end of the 5-year period. Throughout these individuals' lifetimes, this change in CRC screening/testing results in an estimated 498 CRC cases averted with Medicaid expansion and 6031 averted with Medicare-for-all, and an additional 1782 cases if health insurance gains associated with ACA are lost. Estimated cost savings - balancing increased CRC screening/testing costs against decreased cancer treatment costs - are approximately $30 M and $970 M for Medicaid expansion and Medicare-for-all scenarios, respectively, compared to status quo. Insurance expansion is likely to improve CRC screening both overall and in underserved populations while saving money, with the largest savings realized by Medicare.}, journal={PREVENTIVE MEDICINE}, author={Lich, Kristen Hassmiller and Meghan C. O'Leary and Nambiar, Siddhartha and Townsley, Rachel M. and Mayorga, Maria E. and Hicklin, Karen and Frerichs, Leah and Shafer, Paul R. and Davis, Melinda M. and Wheeler, Stephanie B.}, year={2019}, month={Dec} }
 @article{orman_mayorga_wheeler_townsley_toro-diaz_hayashi_sidney barritt_2015, title={Declining liver graft quality threatens the future of liver transplantation in the United States}, volume={21}, ISSN={1527-6465}, url={http://dx.doi.org/10.1002/lt.24160}, DOI={10.1002/lt.24160}, abstractNote={National liver transplantation (LT) volume has declined since 2006, in part because of worsening donor organ quality. Trends that degrade organ quality are expected to continue over the next 2 decades. We used the United Network for Organ Sharing (UNOS) database to inform a 20‐year discrete event simulation estimating LT volume from 2010 to 2030. Data to inform the model were obtained from deceased organ donors between 2000 and 2009. If donor liver utilization practices remain constant, utilization will fall from 78% to 44% by 2030, resulting in 2230 fewer LTs. If transplant centers increase their risk tolerance for marginal grafts, utilization would decrease to 48%. The institution of “opt‐out” organ donation policies to increase the donor pool would still result in 1380 to 1866 fewer transplants. Ex vivo perfusion techniques that increase the use of marginal donor livers may stabilize LT volume. Otherwise, the number of LTs in the United States will decrease substantially over the next 15 years. In conclusion, the transplant community will need to accept inferior grafts and potentially worse posttransplant outcomes and/or develop new strategies for increasing organ donation and utilization in order to maintain the number of LTs at the current level. Liver Transpl 21:1040‐1050, 2015. © 2015 AASLD.}, number={8}, journal={Liver Transplantation}, publisher={Wiley}, author={Orman, Eric S. and Mayorga, Maria E. and Wheeler, Stephanie B. and Townsley, Rachel M. and Toro-Diaz, Hector H. and Hayashi, Paul H. and Sidney Barritt, A., IV}, year={2015}, month={Jul}, pages={1040–1050} }